Ernst-Rudolf Kempe

Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a Cancer Vaccine Consisting of Autologous Cancer Cells Transfected with the Human IL-2 Gene. University of Vienna, Austria

Georg Stingl, E.‐B. Bröcker, Roland Mertelsmann et al. · Human Gene Therapy · 1996 · 39 citations

Human Il-2, Immunology, Immunoediting +22

Genotypic variations in ethanol effect on striatal and hippocampal transmitter interactions

Ernst-Rudolf Kempe, G. Fuhrmann, A. Ebel · Alcohol · 1985 · 20 citations

Ethanol Effect, Cognitive Science, Genotypic Variations +10

Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man.

H. M. Brecht, W.S. Adamus, H. Heuer et al. · PubMed · 1991 · 16 citations

Inflammation, Thrombosis, Molecular Pharmacology +13

Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia

G. Giers, H. Janzarik, Ernst-Rudolf Kempe et al. · Annals of Hematology · 1990 · 15 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +11

Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

Georg Stingl, E.‐B. Bröcker, Roland Mertelsmann et al. · Journal of Molecular Medicine · 1997 · 14 citations

Cancer Immunosurveillance, Metastatic Malignant Melanoma, Melanoma +9